Inventor

AVERBACK PAUL

BS41 patents

⚠️ This page may combine multiple inventors who share the name “AVERBACK PAUL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AVERBACK PAUL

NYMOX CORP

Compositions containing bacteriophages and methods of using bacteriophages to treat infections

Peptides effective in the treatment of conditions requiring the removal or destruction of cells

Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells

Spheron component peptides and pharmaceutical compositions

Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis or growth of DMS

Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells

NTP-peptides and method for removal of tumors

Method of preventing or reducing the progression of prostate cancer

Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis of DMS

Focal treatment of prostate cancer

Method of enhancing the therapeutic efficacy of fexapotide triflutate in treating LUTS

Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia

Focal treatment of prostate cancer

Method of enhancing the therapeutic efficacy of fexapotide triflutate in treating LUTS

Method of treating lower urinary tract symptoms with fexapotide triflutate

Methods of treating multifocal cancer

Pharmaceutical agents that impede the initiation and progression of primary and secondary DMS disruptions

Method of treating benign prostatic hyperlasia with antibiotics

Method of ameliorating or preventing the worsening or the progression of symptoms of BPH

Compositions and methods for improving sexual function

Method of preventing or reducing the incidence of acute urinary retention

Protein and its use in diagnosing Alzheimer&#39;s disease

Pharmaceutical agents that impede the initiation and progression of primary and secondary DMS disruptions

NYMOX PHARMACEUTICAL CORP

Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells

Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells

Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells

Bacteriophage composition useful in treating food products to prevent bacterial contamination

Antibodies to components of dense microspheres and methods of using the same

Method of identifying individuals at risk of suffering from cerebral amyloidosis

Preferred segments of neural thread protein

AVERBACK PAUL

Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells

Antibodies to dense microspheres

Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells

Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells

Microspheric bodies for use in screening therapies for Azheimer&#39;s disease and related conditions

Method for detecting the ability to prevent red-to-green congophilic birefringence

DMS PHARMACEUTICAL INC

Pharmaceutically active agents that impede amyloid formation in vivo

Pharmaceutically active agents that impede amyloid formation in vivo

Isolated components of dense microspheres derived from mammalian brain tissue and antibodies thereto

(unassigned)

Compositions containing bacteriophages and methods of using bacteriophages to treat infections

QUALCOMM INC

Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells

Protein and its use in diagnosing Alzheimer's disease

Microspheric bodies for use in screening therapies for Azheimer's disease and related conditions